In this study, we found frequent AIB1 amplification and overexpression in a cohort of gastric cancers, and demonstrated that genomic amplification was one of the major mechanisms for AIB1 overexpression in gastric cancer. This evidence concerns the gene NCOA3 and gastric cancer.